A randomised controlled trial of the effects of reflexology on mood, coping and quality of life in women with early breast cancer

ISRCTN ISRCTN87652313
DOI https://doi.org/10.1186/ISRCTN87652313
Secondary identifying numbers NCP2/X229
Submission date
12/09/2005
Registration date
03/11/2005
Last edited
09/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Leslie G Walker
Scientific

Institute of Rehabilitation
University of Hull
215 Anlaby Rd
KIngston upon Hull
HU3 2PG
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectives1. Reflexology will be superior to a comparator contact intervention (massage) and treatment as usual (self-initiated support) in terms of its effect on quality of life
2. Reflexology will be acceptable to patients with early breast cancer as manifest by high levels of patient satisfaction and a high uptake of reflexology sessions
3. Reflexology will enhance perceived self control of health
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEarly breast cancer.
InterventionIntervention 1: self-initiated support in the Oncology Health Centres (treatment as usual)

Intervention 2: self-initiated support in the Oncology Health Centres plus scalp massage (comparator physical and social contact intervention)

Intervention 3: self-initiated support in the Oncology Health Centres plus reflexology (a standard foot reflexology routine)
Intervention typeOther
Primary outcome measureThe primary outcome measures will be patient acceptability (number of sessions of reflexology actually attended) and scores on the Clinical Trials Index derived from the Functional Assessment of Cancer Therapy: Breast Version (FACT-B) at week 18.
Secondary outcome measures1. Mood Rating Scale (MRS)
2. Patient Satisfaction Questionnaire (PSQ)
3. FACT-B at week 24
Overall study start date01/04/2002
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants180
Key inclusion criteriaNewly diagnosed early breast cancer (T1, T2 <3 cm, N0, N1a, M0).
Key exclusion criteria1. Unable to complete the study questionnaires
2. Unwilling to give written informed consent
Date of first enrolment01/04/2002
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Institute of Rehabilitation
KIngston upon Hull
HU3 2PG
United Kingdom

Sponsor information

NHS Research and Development National Cancer Programme (UK)
Government

Dr H Campbell
Peninsula Medical School
Haighton Building
St Luke's Campus
Exeter
EX1 2LU
United Kingdom

Phone +44(0)1392 262 929
Email h.e.bailey@exeter.ac.uk
Website http://www.exeter.ac.uk/shhs/canc

Funders

Funder type

Government

NHS R&D National Cancer Programme

No information available

NCP/X229.

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2010 Yes No